Transient-expression technologies, their application and scale-up: 5-HT3 serotonin receptor case study.
Blasey
H D
HD
Serono Pharmaceutical Research Institute, Geneva, Switzerland.
Hovius
R
R
Vogel
H
H
Bernard
A R
AR
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D019309:Epstein-Barr Virus Nuclear Antigens / Q000235:genetics; D015870:Gene Expression; D005822:Genetic Vectors; D006801:Humans; D011985:Receptors, Serotonin / Q000096:biosynthesis / Q000235:genetics* / Q000302:isolation & purification; D044406:Receptors, Serotonin, 5-HT3; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000302:isolation & purification; D012672:Semliki forest virus / Q000235:genetics; D012995:Solubility
D019309:Epstein-Barr Virus Nuclear Antigens; D011985:Receptors, Serotonin; D044406:Receptors, Serotonin, 5-HT3; D011994:Recombinant Proteins